Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease
about
Age impacts pulmonary inflammation and systemic bone response to inhaled orgnic dust exposureSystemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic DustCytokine inhibition in the treatment of COPD.Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma.The Dose-Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations.Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.Mobile-phone-based home exercise training program decreases systemic inflammation in COPD: a pilot studyUpdate on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkersConstant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPDFunctional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease.Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysemaAnti-inflammatory effects of potato extract on a rat model of cigarette smoke-induced chronic obstructive pulmonary disease.A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationPreserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPDTargeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Microarray analysis of long non-coding RNAs in COPD lung tissue.The Gut-Liver-Lung Axis. Modulation of the Innate Immune Response and Its Possible Role in Chronic Obstructive Pulmonary Disease.Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.HIV infection model of chronic obstructive pulmonary disease in mice.Ghrelin Inhibits Interleukin-6 Production Induced by Cigarette Smoke Extract in the Bronchial Epithelial Cell Via NF-κB Pathway.Beyond BMI: Obesity and Lung Disease.Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients.Interleukin-6 and statin therapy: potential role in the management of COPD.Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study.Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.A model of cigarette smoke induced COPD identifies Nrf2 signaling as an expedient target for interventionElevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation
P2860
Q23914900-88542142-E6FC-40B0-9CFC-7B0D8DF2DA75Q29048648-EFE8348A-763F-44BD-95D9-5CEECDB60161Q33568552-D91DD142-FDA2-432E-9136-15F175E9079DQ33569149-D242E9A8-DFC5-4741-8A72-CB3F987276F7Q33755148-EBACC662-D7F8-4DC9-831A-9529C8120730Q34005625-50E2253D-C657-42FC-A846-51E42B073766Q34539050-2D07B6DC-2F5B-4BB1-9A86-A4497B07127CQ34656726-1CC306D1-8274-4183-8504-55C7428FD8D8Q35077055-C74187D6-7B0D-42FC-93C6-F5C2BB6F04D0Q35312449-E6E96F6B-A1D2-441B-ABD3-F7D5B61759AFQ35892456-7913EBF5-9F38-467D-BBBD-A335C090377EQ36000101-15F1D711-EEE5-46F6-B7D5-252F40D3EF1CQ36105708-B9DFEFA1-DC09-40EF-808A-138359D46F99Q36206448-2F930EB9-7556-43A2-9651-E4ACB200D9AAQ36754116-6DFEB80C-3322-427F-B312-0052FBCA37F1Q37501498-1B01171E-1382-4B40-A161-E09C58B2A8DCQ37734257-707FCAA3-9DF3-4E95-9646-77B05A1C2E16Q38468602-61D46984-0E4E-4662-A9E0-8B2AA8F28E76Q38608866-C5C46074-CE8C-440C-BD7F-215F4DBCE804Q38710985-14394C33-074C-4426-893A-1CC749C1C3E0Q38768300-C09A360E-BB0A-4EB6-BC92-A2F5D52E25C6Q38843459-C2E8C75D-6A94-4A1D-BCD7-567E771EF9D3Q39448575-DEFCB5A3-5FFC-4845-856A-E35CEF5E54ABQ42146567-9778BEED-6E59-4C1E-A36B-832B06A22899Q43081658-83DED068-77E1-47CD-8A46-657699A5387AQ47112547-B590BF23-6E1E-4DA7-A44F-7C035B332838Q50602624-2459BC79-09ED-462B-AAFC-C5519B366DFFQ58700499-B2A455C7-609F-4D22-A1F1-4C800230BEF5Q58770879-A25348A2-73F4-4644-8F4B-1D15EB9BD5D2
P2860
Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Three-year follow-up of Interl ...... obstructive pulmonary disease
@en
type
label
Three-year follow-up of Interl ...... obstructive pulmonary disease
@en
prefLabel
Three-year follow-up of Interl ...... obstructive pulmonary disease
@en
P2093
P2860
P50
P356
P1433
P1476
Three-year follow-up of Interl ...... obstructive pulmonary disease
@en
P2093
Camila R Corrêa
Corina Corrêa
Renata Ferrari
P2860
P2888
P356
10.1186/1465-9921-14-24
P577
2013-02-20T00:00:00Z
P5875
P6179
1025418972